Fasslrinner, F., Schetelig, J., Burchert, A., Kramer, M., Trenschel, R., Hegenbart, U., Stadler, M., Schäfer-Eckart, K., Bätzel, M., Eich, H., Stuschke, M., Engenhart-Cabillic, R., Krause, M., Dreger, P., Neubauer, A., Ehninger, G., Beelen, D., Berdel, W. E., Siepmann, T., Stelljes, M., & Bornhäuser, M. (2018). long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial. Lancet, 5(4), e161–e169. http://access.bl.uk/ark:/81055/vdc_100059053381.0x000001